Efoora to test rapid HIV test in the US:
This article was originally published in Clinica
Efoora has gained permission from the US FDA to begin clinical trials of its rapid HIV screening test. The HIV Rapid test will be assessed at a number of US centres and data generated from the studies will be used to support a premarket approval application for the product. The test, which is sensitive to HIV antibodies indicative of infection, can produce a result in 20 minutes, says the Buffalo Grove, Illinois firm.